Caliway Biopharmaceuticals Co., Ltd. announced a oversubscribed private placement that it has issued 8,000,000 new shares at a price of $12.5 per share for the gross proceeds of $100 million on December 16, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
489.5 TWD | +8.78% | +17.53% | +155.95% |
1st Jan change | Capi. | |
---|---|---|
+155.95% | 1.94B | |
+47.58% | 779B | |
+40.67% | 631B | |
-6.69% | 354B | |
+20.46% | 333B | |
+8.26% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.25% | 163B |
- Stock Market
- Equities
- 6919 Stock
- News Caliway Biopharmaceuticals Co., Ltd.
- Caliway Biopharmaceuticals Co., Ltd. announced that it has received $100 million in funding